enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Apremilast - Wikipedia

   en.wikipedia.org/wiki/Apremilast

   Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. [4] The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). [ 4 ]

3. PDE4 inhibitor - Wikipedia

   en.wikipedia.org/wiki/PDE4_inhibitor

   Apremilast, a phthalimide derivative that was approved by the U.S. FDA in March 2014 for use as a treatment for psoriatic arthritis, [21] and in September 2014 for the treatment of plaque psoriasis under the brand name Otezla.

4. Medicare announces weight-loss drugs, including Ozempic ... - AOL

   www.aol.com/medicare-announces-15-drugs-price...

   Otezla, a psoriatic arthritis drug. Juliette Cubanski, deputy director of the Medicare policy program at KFF, a nonprofit group that researches health policy issues, said the stakes for the ...

5. Ozempic, Wegovy and other drugs are among 15 selected for ...

   www.aol.com/ozempic-wegovy-other-drugs-selected...

   Besides Ozempic and Wegovy, some of the other medications include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug; and several that treat different forms of cancer.

6. Ozempic and Wegovy selected for next round of Medicare drug ...

   www.aol.com/ozempic-wegovy-selected-next-round...

   Otezla, treats plaque psoriasis, psoriatic arthritis, certain oral ulcers. Novo Nordisk, which has filed a lawsuit against the Biden administration for including its insulin medications NovoLog ...

7. List of largest pharmaceutical mergers and acquisitions

   en.wikipedia.org/wiki/List_of_largest...

   Rank Year Purchaser Target Value (in billions USD) Value (adjusted for inflation) 1 2015 Pfizer: Allergan, plc: 160 206 In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation).

8. The Dow Jones Industrials Are Winning 2025: 4 Highest ... - AOL

   www.aol.com/dow-jones-industrials-winning-2025...

   Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behcet's disease Aranesp to treat a lower-than-normal number of red blood ...

9. Biological response modifier - Wikipedia

   en.wikipedia.org/wiki/Biological_response_modifier

   Biological response modifiers (BRMs) are substances that modify immune responses.They can be endogenous (produced naturally within the body) or exogenous (as pharmaceutical drugs), and they can either enhance an immune response or suppress it.